[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"fibroadenoma\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:fibroadenoma":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,40],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100456139","medical-imaging-and-thermal-treatment-for-breast-tumors-using-harmonic-motion-imaging-hmi-100456139",false,"NCT05219695","Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)","Inclusion Criteria:\n\n* Women age ≥18\n* Patients with fibroadenoma (benign tumor) or early-stage, non-metastatic breast cancer (stage I without the involvement of axillary lymph nodes)\n* Scheduled to receive surgical resection of the tumor by the clinical care team (ideal target lesion upper boundary should be deeper than 1 cm below the skin, and the ideal size of the lesion should be 2-5 cm in diameter)\n\nExclusion Criteria:\n\n* Pregnant or lactating women\n* Patients with breast implants\n* Patients with a history of laser or radiation therapy to the targeted breast\n* Patients who have received or are scheduled to receive thermal ablation or treatment of the tumor (other than surgery) as part of clinical care","FEMALE","18 Years",{"count":18,"type":19},36,"ESTIMATED","INTERVENTIONAL",[22],"NA","The objective of this study is to demonstrate the initial clinical feasibility of using Harmonic Motion Imaging (HMI) for Focused Ultrasound Surgery (FUS) guidance and monitoring in patients with benign and stage 1 non-metastatic breast cancers. The investigators hypothesize that changes in HMI parameters will inform progression of FUS ablation.",[25,26],"Fibroadenoma","Breast Cancer Stage I","RECRUITING","2025-05-28",{"date":30,"type":31},"2025-05-31","ACTUAL",{"date":33,"type":31},"2022-01-19",{"date":35,"type":19},"2026-05",{"name":37,"class":38},"Columbia University","OTHER",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":47,"targetDuration":4,"studyType":20,"phases":49,"briefSummary":50,"conditions":51,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":39},"100576005","regional-anesthesia-techniques-in-breast-surgery-100576005","NCT06779656","Regional Anesthesia Techniques in Breast Surgery","Regional Anesthesia Techniques in Breast Surgery: a Comparative Study","Inclusion Criteria:\n\n* American Society of Anesthesiologists (ASA) physical status classification I-III.\n* Age of 18 years or older.\n* Scheduled to undergo breast surgery, including augmentation, fibroadenoma excision, or mastectomy.\n\nExclusion Criteria:\n\n* Known allergy to local anesthetics.\n* Pregnancy or lactation.\n* Coagulation disorders.\n* Severe cardiopulmonary disease.\n* Local infection at the injection site.\n* Unstable psychiatric illness.",{"count":48,"type":19},180,[22],"This clinical trial aims to evaluate the efficacy of liposomal bupivacaine and ropivacaine, when administered via paravertebral block, the rhomboid intercostal and subserratus plane (RISS) block, PECS II block, intercostal nerve block, serratus anterior plane block, or epidural block, in patients undergoing breast surgery (including augmentation, fibroadenoma excision, and mastectomy). The primary objectives are to determine:\n\n1. Whether the use of liposomal bupivacaine or ropivacaine reduces the postoperative analgesic requirements in participants.\n2. What potential adverse events participants experience when using liposomal bupivacaine or ropivacaine.\n3. Which of the following regional anesthesia techniques provides superior analgesia: paravertebral block, RISS block, PECS II block, intercostal nerve block, serratus anterior plane block, or epidural block.\n\nParticipants will undergo one of the following regional anesthesia techniques upon arrival to the surgical suite: paravertebral block, RISS block, PECS II block, intercostal nerve block, serratus anterior plane block, or epidural block. Following regional anesthesia administration, general anesthesia with endotracheal intubation will be performed. Participants' vital signs, postoperative analgesic consumption, and recovery will be recorded.",[52,25,53],"Augmentation","Mastectomy","NOT_YET_RECRUITING","2025-01-16",{"date":57,"type":31},"2025-01-17",{"date":59,"type":19},"2025-02-01",{"date":61,"type":19},"2025-05-10",{"name":63,"class":38},"Xiaguang Duan"]